Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Polyphenylene carboxymethylene (PPCM) in vitro antiviral efficacy against Ebola virus in the context of a sexually transmitted infection.

Escaffre O, Juelich TL, Freiberg AN.

Antiviral Res. 2019 Jul 24;170:104567. doi: 10.1016/j.antiviral.2019.104567. [Epub ahead of print]

PMID:
31351092
2.

Repurposing Quinacrine Against Ebola Virus Infection In vivo.

Lane TR, Comer JE, Freiberg AN, Madrid PB, Ekins S.

Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.01142-19. doi: 10.1128/AAC.01142-19. [Epub ahead of print]

PMID:
31307979
3.

Henipavirus infection of the central nervous system.

Dawes BE, Freiberg AN.

Pathog Dis. 2019 Mar 1;77(2). pii: ftz023. doi: 10.1093/femspd/ftz023.

PMID:
30985897
4.

Filovirus Virulence in Interferon α/β and γ Double Knockout Mice, and Treatment with Favipiravir.

Comer JE, Escaffre O, Neef N, Brasel T, Juelich TL, Smith JK, Smith J, Kalveram B, Perez DD, Massey S, Zhang L, Freiberg AN.

Viruses. 2019 Feb 3;11(2). pii: E137. doi: 10.3390/v11020137.

5.

A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice.

Terasaki K, Juelich TL, Smith JK, Kalveram B, Perez DD, Freiberg AN, Makino S.

Sci Rep. 2018 Nov 20;8(1):17097. doi: 10.1038/s41598-018-35472-7.

6.

Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines.

Dawes BE, Gao J, Atkins C, Nelson JT, Johnson K, Wu P, Freiberg AN.

J Neuroinflammation. 2018 Nov 15;15(1):315. doi: 10.1186/s12974-018-1356-5.

7.

Natural History and Pathogenesis of Wild-Type Marburg Virus Infection in STAT2 Knockout Hamsters.

Atkins C, Miao J, Kalveram B, Juelich T, Smith JK, Perez D, Zhang L, Westover JLB, Van Wettere AJ, Gowen BB, Wang Z, Freiberg AN.

J Infect Dis. 2018 Nov 22;218(suppl_5):S438-S447. doi: 10.1093/infdis/jiy457.

PMID:
30192975
8.

Imaging of Murine Whole Lung Fibrosis by Large Scale 3D Microscopy aided by Tissue Optical Clearing.

Ochoa LF, Kholodnykh A, Villarreal P, Tian B, Pal R, Freiberg AN, Brasier AR, Motamedi M, Vargas G.

Sci Rep. 2018 Sep 6;8(1):13348. doi: 10.1038/s41598-018-31182-2.

9.

Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription

Tigabu B, Ramanathan P, Ivanov A, Lin X, Ilinykh PA, Parry CS, Freiberg AN, Nekhai S, Bukreyev A.

J Virol. 2018 Oct 12;92(21). pii: e00426-18. doi: 10.1128/JVI.00426-18. Print 2018 Nov 1.

10.

Experimental Infection of Syrian Hamsters With Aerosolized Nipah Virus.

Escaffre O, Hill T, Ikegami T, Juelich TL, Smith JK, Zhang L, Perez DE, Atkins C, Park A, Lawrence WS, Sivasubramani SK, Peel JE, Peterson JW, Lee B, Freiberg AN.

J Infect Dis. 2018 Oct 5;218(10):1602-1610. doi: 10.1093/infdis/jiy357.

PMID:
29912426
11.

Favipiravir (T-705) protects against Nipah virus infection in the hamster model.

Dawes BE, Kalveram B, Ikegami T, Juelich T, Smith JK, Zhang L, Park A, Lee B, Komeno T, Furuta Y, Freiberg AN.

Sci Rep. 2018 May 15;8(1):7604. doi: 10.1038/s41598-018-25780-3.

12.

Distinct virulence of Rift Valley fever phlebovirus strains from different genetic lineages in a mouse model.

Ikegami T, Balogh A, Nishiyama S, Lokugamage N, Saito TB, Morrill JC, Shivanna V, Indran SV, Zhang L, Smith JK, Perez D, Juelich TL, Morozov I, Wilson WC, Freiberg AN, Richt JA.

PLoS One. 2017 Dec 21;12(12):e0189250. doi: 10.1371/journal.pone.0189250. eCollection 2017.

13.

Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection.

McAuley AJ, Sawatsky B, Ksiazek T, Torres M, Korva M, Lotrič-Furlan S, Avšič-Županc T, von Messling V, Holbrook MR, Freiberg AN, Beasley DWC, Bente DA.

NPJ Vaccines. 2017 Mar 13;2:5. doi: 10.1038/s41541-017-0009-5. eCollection 2017.

14.

Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection.

Atkins C, Freiberg AN.

Future Virol. 2017 Nov;12(11):651-665. doi: 10.2217/fvl-2017-0060. Epub 2017 Oct 23. Review.

15.

Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.

Ekins S, Lingerfelt MA, Comer JE, Freiberg AN, Mirsalis JC, O'Loughlin K, Harutyunyan A, McFarlane C, Green CE, Madrid PB.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01711-17. doi: 10.1128/AAC.01711-17. Print 2018 Feb.

16.

Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.

Ly HJ, Nishiyama S, Lokugamage N, Smith JK, Zhang L, Perez D, Juelich TL, Freiberg AN, Ikegami T.

Vaccine. 2017 Dec 4;35(48 Pt B):6634-6642. doi: 10.1016/j.vaccine.2017.10.036. Epub 2017 Oct 20.

17.

The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.

Bharaj P, Atkins C, Luthra P, Giraldo MI, Dawes BE, Miorin L, Johnson JR, Krogan NJ, Basler CF, Freiberg AN, Rajsbaum R.

J Virol. 2017 Aug 24;91(18). pii: e00833-17. doi: 10.1128/JVI.00833-17. Print 2017 Sep 15.

18.

Contribution of Human Lung Parenchyma and Leukocyte Influx to Oxidative Stress and Immune System-Mediated Pathology following Nipah Virus Infection.

Escaffre O, Saito TB, Juelich TL, Ikegami T, Smith JK, Perez DD, Atkins C, Levine CB, Huante MB, Nusbaum RJ, Endsley JJ, Freiberg AN, Rockx B.

J Virol. 2017 Jul 12;91(15). pii: e00275-17. doi: 10.1128/JVI.00275-17. Print 2017 Aug 1.

19.

Efficient and Robust Paramyxoviridae Reverse Genetics Systems.

Beaty SM, Park A, Won ST, Hong P, Lyons M, Vigant F, Freiberg AN, tenOever BR, Duprex WP, Lee B.

mSphere. 2017 Mar 29;2(2). pii: e00376-16. doi: 10.1128/mSphere.00376-16. eCollection 2017 Mar-Apr.

20.

Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA Viruses.

Bazhanov N, Escaffre O, Freiberg AN, Garofalo RP, Casola A.

Sci Rep. 2017 Jan 20;7:41029. doi: 10.1038/srep41029.

21.

The Matrix Protein of Nipah Virus Targets the E3-Ubiquitin Ligase TRIM6 to Inhibit the IKKε Kinase-Mediated Type-I IFN Antiviral Response.

Bharaj P, Wang YE, Dawes BE, Yun TE, Park A, Yen B, Basler CF, Freiberg AN, Lee B, Rajsbaum R.

PLoS Pathog. 2016 Sep 13;12(9):e1005880. doi: 10.1371/journal.ppat.1005880. eCollection 2016 Sep.

22.

Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.

Nishiyama S, Slack OA, Lokugamage N, Hill TE, Juelich TL, Zhang L, Smith JK, Perez D, Gong B, Freiberg AN, Ikegami T.

Virulence. 2016 Nov 16;7(8):871-881. Epub 2016 Jun 1.

23.

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.

Phoenix I, Nishiyama S, Lokugamage N, Hill TE, Huante MB, Slack OA, Carpio VH, Freiberg AN, Ikegami T.

Viruses. 2016 May 23;8(5). pii: E149. doi: 10.3390/v8050149.

24.

Nipah Virus C Protein Recruits Tsg101 to Promote the Efficient Release of Virus in an ESCRT-Dependent Pathway.

Park A, Yun T, Vigant F, Pernet O, Won ST, Dawes BE, Bartkowski W, Freiberg AN, Lee B.

PLoS Pathog. 2016 May 20;12(5):e1005659. doi: 10.1371/journal.ppat.1005659. eCollection 2016 May.

25.

ISG15 deficiency and increased viral resistance in humans but not mice.

Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E, Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, García-Sastre A, Pellegrini S, Bogunovic D.

Nat Commun. 2016 May 19;7:11496. doi: 10.1038/ncomms11496.

26.

Optimized P2A for reporter gene insertion into Nipah virus results in efficient ribosomal skipping and wild-type lethality.

Park A, Yun T, Hill TE, Ikegami T, Juelich TL, Smith JK, Zhang L, Freiberg AN, Lee B.

J Gen Virol. 2016 Apr;97(4):839-43. doi: 10.1099/jgv.0.000405. Epub 2016 Jan 18.

27.

Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.

Ikegami T, Hill TE, Smith JK, Zhang L, Juelich TL, Gong B, Slack OA, Ly HJ, Lokugamage N, Freiberg AN.

J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.

28.

Evidence for ubiquitin-regulated nuclear and subnuclear trafficking among Paramyxovirinae matrix proteins.

Pentecost M, Vashisht AA, Lester T, Voros T, Beaty SM, Park A, Wang YE, Yun TE, Freiberg AN, Wohlschlegel JA, Lee B.

PLoS Pathog. 2015 Mar 17;11(3):e1004739. doi: 10.1371/journal.ppat.1004739. eCollection 2015 Mar.

29.

Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus.

Roberts KK, Hill TE, Davis MN, Holbrook MR, Freiberg AN.

J Gen Virol. 2015 Jul;96(Pt 7):1651-1663. doi: 10.1099/vir.0.000119. Epub 2015 Mar 10.

30.

Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola Vaccine.

Choi JH, Schafer SC, Freiberg AN, Croyle MA.

Mol Pharm. 2015 Aug 3;12(8):2697-711. doi: 10.1021/mp5006454. Epub 2015 Jan 20.

31.

Timing of galectin-1 exposure differentially modulates Nipah virus entry and syncytium formation in endothelial cells.

Garner OB, Yun T, Pernet O, Aguilar HC, Park A, Bowden TA, Freiberg AN, Lee B, Baum LG.

J Virol. 2015 Mar;89(5):2520-9. doi: 10.1128/JVI.02435-14. Epub 2014 Dec 10.

32.

Evidence for henipavirus spillover into human populations in Africa.

Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, Zachariah TT, Bowden TA, Hitchens P, Ramirez CM, Daszak P, Mazet J, Freiberg AN, Wolfe ND, Lee B.

Nat Commun. 2014 Nov 18;5:5342. doi: 10.1038/ncomms6342.

33.

Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.

Yun T, Park A, Hill TE, Pernet O, Beaty SM, Juelich TL, Smith JK, Zhang L, Wang YE, Vigant F, Gao J, Wu P, Lee B, Freiberg AN.

J Virol. 2015 Jan 15;89(2):1242-53. doi: 10.1128/JVI.02583-14. Epub 2014 Nov 12.

34.

Multiplexed digital mRNA profiling of the inflammatory response in the West Nile Swiss Webster mouse model.

Peña J, Plante JA, Carillo AC, Roberts KK, Smith JK, Juelich TL, Beasley DW, Freiberg AN, Labute MX, Naraghi-Arani P.

PLoS Negl Trop Dis. 2014 Oct 23;8(10):e3216. doi: 10.1371/journal.pntd.0003216. eCollection 2014 Oct.

35.

Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, Doggett NA, Dolnik O, Dye JM, Enterlein S, Fenimore PW, Formenty P, Freiberg AN, Garry RF, Garza NL, Gire SK, Gonzalez JP, Griffiths A, Happi CT, Hensley LE, Herbert AS, Hevey MC, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson JC, Johnson KM, Kindrachuk J, Klenk HD, Kobinger G, Kochel TJ, Lackemeyer MG, Lackner DF, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Omilabu SA, Palacios G, Panchal RG, Park DJ, Patterson JL, Paweska JT, Peters CJ, Pettitt J, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Sabeti PC, Sealfon R, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Viruses. 2014 Sep 26;6(9):3663-82. doi: 10.3390/v6093663.

36.

Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription.

Ilinykh PA, Tigabu B, Ivanov A, Ammosova T, Obukhov Y, Garron T, Kumari N, Kovalskyy D, Platonov MO, Naumchik VS, Freiberg AN, Nekhai S, Bukreyev A.

J Biol Chem. 2014 Aug 15;289(33):22723-38. doi: 10.1074/jbc.M114.575050. Epub 2014 Jun 16.

37.

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever.

Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK, Zhang L, Tigabu B, Hill TE, Yun T, Pietzsch C, Furuta Y, Freiberg AN.

PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2614. doi: 10.1371/journal.pntd.0002614. eCollection 2013.

38.

Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.

Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Hoenen T, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Volchkova VA, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2014 May;159(5):1229-37. doi: 10.1007/s00705-013-1877-2. Epub 2013 Nov 5.

39.

Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.

Choi JH, Schafer SC, Zhang L, Juelich T, Freiberg AN, Croyle MA.

Mol Pharm. 2013 Sep 3;10(9):3342-55. doi: 10.1021/mp4001316. Epub 2013 Aug 19.

40.

Coagulation factors, fibrinogen and plasminogen activator inhibitor-1, are differentially regulated by yellow fever virus infection of hepatocytes.

Woodson SE, Freiberg AN, Holbrook MR.

Virus Res. 2013 Aug;175(2):155-9. doi: 10.1016/j.virusres.2013.04.013. Epub 2013 Apr 29.

PMID:
23639427
41.

Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.

Lihoradova OA, Indran SV, Kalveram B, Lokugamage N, Head JA, Gong B, Tigabu B, Juelich TL, Freiberg AN, Ikegami T.

PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2181. doi: 10.1371/journal.pntd.0002181. Print 2013.

42.

A mechanistic paradigm for broad-spectrum antivirals that target virus-cell fusion.

Vigant F, Lee J, Hollmann A, Tanner LB, Akyol Ataman Z, Yun T, Shui G, Aguilar HC, Zhang D, Meriwether D, Roman-Sosa G, Robinson LR, Juelich TL, Buczkowski H, Chou S, Castanho MA, Wolf MC, Smith JK, Banyard A, Kielian M, Reddy S, Wenk MR, Selke M, Santos NC, Freiberg AN, Jung ME, Lee B.

PLoS Pathog. 2013;9(4):e1003297. doi: 10.1371/journal.ppat.1003297. Epub 2013 Apr 18.

43.

The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.

Lubaki NM, Ilinykh P, Pietzsch C, Tigabu B, Freiberg AN, Koup RA, Bukreyev A.

J Virol. 2013 Jul;87(13):7471-85. doi: 10.1128/JVI.03316-12. Epub 2013 Apr 24. Erratum in: J Virol. 2013 Nov;87(22):12506.

44.

Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.

Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, Gong B, Freiberg AN, Ikegami T.

J Gen Virol. 2013 Jul;94(Pt 7):1441-50. doi: 10.1099/vir.0.051250-0. Epub 2013 Mar 20.

45.

Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Lofts LL, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST.

Arch Virol. 2013 Jun;158(6):1425-32. doi: 10.1007/s00705-012-1594-2. Epub 2013 Jan 29. No abstract available.

46.

Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol.

Liu SY, Aliyari R, Chikere K, Li G, Marsden MD, Smith JK, Pernet O, Guo H, Nusbaum R, Zack JA, Freiberg AN, Su L, Lee B, Cheng G.

Immunity. 2013 Jan 24;38(1):92-105. doi: 10.1016/j.immuni.2012.11.005. Epub 2012 Dec 27.

47.

Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.

Lokugamage N, Freiberg AN, Morrill JC, Ikegami T.

J Virol. 2012 Dec;86(24):13566-75. doi: 10.1128/JVI.02081-12. Epub 2012 Oct 3.

48.

Detection of severe fever with thrombocytopenia syndrome virus by reverse transcription-cross-priming amplification coupled with vertical flow visualization.

Cui L, Ge Y, Qi X, Xu G, Li H, Zhao K, Wu B, Shi Z, Guo X, Hu L, You Q, Zhang LH, Freiberg AN, Yu X, Wang H, Zhou M, Tang YW.

J Clin Microbiol. 2012 Dec;50(12):3881-5. doi: 10.1128/JCM.01931-12. Epub 2012 Sep 19.

49.

An assembly model of rift valley Fever virus.

Rusu M, Bonneau R, Holbrook MR, Watowich SJ, Birmanns S, Wriggers W, Freiberg AN.

Front Microbiol. 2012 Jul 19;3:254. doi: 10.3389/fmicb.2012.00254. eCollection 2012.

50.

Mutational analysis of positively charged amino acid residues of Uukuniemi phlebovirus nucleocapsid protein.

Katz A, Freiberg AN, Backström V, Holm L, Vaheri A, Flick R, Plyusnin A.

Virus Res. 2012 Jul;167(1):118-23.

PMID:
22808531

Supplemental Content

Loading ...
Support Center